Horse Chestnut Seed Extract for Lymphedema

Completed · Phase 2

Conditions studied: Lymphedema of Arm

In brief

To help Treat Lymphedema of the Arm in Breast Cancer Survivors with Horse chestnut Seed Extract

Key facts

Study ID

NCT00213928

Run by

University of Wisconsin, Madison

People needed

56

Starts

2002-05-01

Expected to finish

2008-09-01

Last updated by the study team

2015-06-02

Who can join

Age: 17 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patient demonstrates unilateral (ipsilateral to breast cancer resection side) lymphedema of the upper extremity. An extravascular water ratio of ³1.1/1 between the affected vs normal arm using multiple-frequency bioelectric impedance will be used as a criterion for lymphedema. There is not upper limit to the extent of arm volume (lymphedema)
• Patient is greater than 6 months from last surgical and/or radiation treatment to the affected axilla.

You may not qualify if…

• Patients may not be receiving or be scheduled to receive cytotoxic or radiation chemotherapy treatment while on this lymphedema study (Last chemotherapy > 4 weeks prior). Women who are being treated adjuvantly with tamoxifen, raloxifene, or an aromatase inhibitor remain eligible
• Patients with a history of recurrent (more than 1 episode) arm cellulitis, prior or existing venous clot, or considered to have "woody" fibrosis of the affected arm are not eligible. Antibiotics used to treat any prior episode of cellulitis must have be completed no more recently than 3 months prior to initial screening.

Where it is running

• University of Wisconsin — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.